GeneDx Holdings Corp. (WGS)
64.69
+1.95
(+3.11%)
USD |
NASDAQ |
Oct 28, 16:00
64.69
0.00 (0.00%)
After-Hours: 19:43
GeneDx Holdings Enterprise Value : 1.905B for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 1.905B |
| October 26, 2026 | 1.861B |
| October 23, 2026 | 1.708B |
| October 22, 2026 | 2.036B |
| October 21, 2026 | 2.089B |
| October 20, 2026 | 2.084B |
| October 19, 2026 | 2.011B |
| October 16, 2026 | 1.931B |
| October 15, 2026 | 2.128B |
| October 14, 2026 | 2.080B |
| October 13, 2026 | 1.971B |
| October 12, 2026 | 1.937B |
| October 09, 2026 | 2.042B |
| October 08, 2026 | 2.053B |
| October 07, 2026 | 2.077B |
| October 06, 2026 | 2.166B |
| October 05, 2026 | 2.308B |
| October 02, 2026 | 2.213B |
| October 01, 2026 | 2.150B |
| September 30, 2026 | 2.190B |
| September 29, 2026 | 2.294B |
| September 28, 2026 | 2.596B |
| September 25, 2026 | 2.669B |
| September 24, 2026 | 2.672B |
| September 23, 2026 | 2.574B |
| Date | Value |
|---|---|
| September 22, 2026 | 2.741B |
| September 21, 2026 | 2.951B |
| September 18, 2026 | 3.048B |
| September 17, 2026 | 3.163B |
| September 16, 2026 | 2.938B |
| September 15, 2026 | 2.855B |
| September 14, 2026 | 2.709B |
| September 11, 2026 | 2.576B |
| September 10, 2026 | 2.537B |
| September 09, 2026 | 2.612B |
| September 08, 2026 | 2.594B |
| September 04, 2026 | 2.598B |
| September 03, 2026 | 2.639B |
| September 02, 2026 | 2.619B |
| September 01, 2026 | 2.562B |
| August 31, 2026 | 2.562B |
| August 28, 2026 | 2.608B |
| August 27, 2026 | 2.694B |
| August 26, 2026 | 2.726B |
| August 25, 2026 | 2.640B |
| August 24, 2026 | 2.574B |
| August 21, 2026 | 2.630B |
| August 20, 2026 | 2.495B |
| August 19, 2026 | 2.409B |
| August 18, 2026 | 2.310B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 9.945B |
| CS Diagnostics Corp. | -- |
| Aibotics, Inc. | 3.441M |
| Intellia Therapeutics, Inc. | 1.355B |
| 10X Genomics, Inc. | 9.691B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.74M |
| Revenue (Quarterly) | 114.44M |
| Total Expenses (Quarterly) | 132.18M |
| EPS Diluted (Quarterly) | -0.5971 |
| Gross Profit Margin (Quarterly) | 64.05% |
| Profit Margin (Quarterly) | -15.50% |
| Earnings Yield | -5.61% |
| Normalized Earnings Yield | -4.027 |